Showing results (301-310 of 3,163) with videos related to
Sort By:
Pageof 317
Translational Oncology|March 17, 2018
Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric CancerRyo Yuge, Yasuhiko Kitadai, Hidehiko Takigawa, et al.Translational Oncology|June 6, 2022
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myelomaMark Sellin, Stephanie Berg, Patrick Hagen, et al.Translational Oncology|June 6, 2022
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancerChristopher Godina, Vineesh Indira Chandran, Magdalena Barbachowska, et al.Translational Oncology|June 9, 2022
Advances in the treatment of extramedullary disease in multiple myelomaYating Li, Zhengxu Sun, Xiaoyan QuTranslational Oncology|May 21, 2022
Advances in PSMA theranosticsThomas M Jeitner, John W Babich, James M KellyTranslational Oncology|June 13, 2022
Effects of USP7 on radiation sensitivity through p53 pathway in laryngeal squamous cell carcinomaHao Niu, Yi Zhu, Jie Wang, et al.Translational Oncology|June 14, 2022
A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysisYu-Qiu Chen, Xiao-Fan Xu, Jia-Wei Xu, et al.Translational Oncology|July 2, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutationsMatteo Canale, Elisabetta Petracci, Paola Cravero, et al.Translational Oncology|January 9, 2021
Development of near-infrared imaging agents for detection of junction adhesion molecule-A proteinE Walker, S M Turaga, X Wang, et al.Translational Oncology|November 22, 2020
Revealing the anticancer potential of candidate drugs in vivo using Caenorhabditis elegans mutant strainsPaul Mark Medina, Jozelle Marie Ponce, Christian Alfredo CruzPageof 317